Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000660228 | SCV000782231 | uncertain significance | Renpenning syndrome | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584519 | SCV001818610 | likely benign | not provided | 2020-10-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001584519 | SCV003248191 | benign | not provided | 2023-12-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003403521 | SCV004104038 | uncertain significance | PQBP1-related disorder | 2023-06-29 | criteria provided, single submitter | clinical testing | The PQBP1 c.397C>T variant is predicted to result in the amino acid substitution p.Arg133Trp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.015% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/X-48759614-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV004026049 | SCV005010585 | likely benign | Inborn genetic diseases | 2023-10-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |